prostate cancer index | prostate cancer | prostatectomy | radiation | hormone | cryosurgery | hifu | wait & see | alternative treatment | diet | articles | contact |

Archive for March, 2009

Study links alcohol, prostate cancer

Saturday, March 14th, 2009 Posted in prostate cancer risks | No Comments »

An international study suggests men who consume two or more standard drinks a day increase their likelihood of developing prostate cancer by 20 per cent. The research by scientists from Australia, Canada and the United States, examined 35 previous studies from ...

Pelvic floor stimulation and biofeedback positive in the early recovery of continence post-surgery

Friday, March 13th, 2009 Posted in prostatectomy | No Comments »

A recent study has. explored the potential benefit of the early combined use of functional pelvic floor electrical stimulation and biofeedback in terms of time to recovery and rate of continence after radical prostatectomy. The authors conclude that early, non-invasive physical ...

3D-Mapping Biopsy Can Impact Prostate Cancer Management: Presented at SIR

Friday, March 13th, 2009 Posted in prostate cancer, prostate cancer diagnosis | No Comments »

A researcher reported at the Society of Interventional Radiology (SIR) 34th Annual Scientific Meeting that ransperineal 3-dimensional prostate-mapping biopsy (3D-PMB) provides superior cancer-staging information when compared with the more traditional ultrasound or transrectal ultrasound (TRUS) when choosing candidates for focal prostate ...

Zinc from supplements associated with reduced risk of advanced prostate cancer

Thursday, March 12th, 2009 Posted in prostate cancer risks | No Comments »

The March, 2009 issue of Nutrition and Cancer published the finding of Seattle's Fred Hutchinson Cancer Research Center of an association between long term consumption of zinc supplements and a reduced risk of advanced prostate cancer in men. Zinc from diet ...

Ongoing Ablatherm-HIFU U.S. Clinical Study Protocol Amended

Wednesday, March 11th, 2009 Posted in hifu | No Comments »

EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, has received approval from U.S. Food and Drug Administration (FDA) to introduce amendaments to the protocol for the ENLIGHT trial. This trial is the Company's ongoing U.S. clinical study of Ablatherm-HIFU ...

Folic acid supplements linked to higher risk of prostate cancer

Tuesday, March 10th, 2009 Posted in prostate cancer risks | No Comments »

A recent study led by researchers at the University of Southern California (USC) concluded that men who took a folic acid supplement of 1 mg daily had more than twice the risk of prostate cancer compared with men who took ...

Review of focal cryotherapy

Tuesday, March 10th, 2009 Posted in prostate cryotherapy | No Comments »

Reviewing the currently available data on whole gland and focal cryotherapy and made a good case for the use of these techniques in appropriately selected patients, a recent study has concluded that the application of focal cryotherapy in relatively low ...

Prostate cancer treatment and the risks on sexual functionality

Tuesday, March 10th, 2009 Posted in prostate cancer | No Comments »

A recent study has reviewed the complex decision processes that men face in making the trade off between effective prostate cancer treatment and the risks for impact on sexual functionality associated with such treatment. Researchers state that, based on their research ...

Freezing prostate cancer does a man’s body good

Monday, March 9th, 2009 Posted in prostate cryotherapy | No Comments »

According to studies released at the Society of Interventional Radiology's 34th Annual Scientific Meeting, focal cryoablation, called "male lumpectomy" - a minimally invasive interventional radiology treatment for prostate cancer - is as effective as surgery in destroying diseased tumors and ...

New Molecular Tests Can Predict the Return of Prostate Cancer

Monday, March 9th, 2009 Posted in prostate cancer diagnosis | No Comments »

Earlier this year Aureon Laboratories released Prostate Px, the first in a series of tests that predict prostate cancer recurrence. The Prostate Px test has two endpoints for cancer recurrence: PSA Recurrence Px Score describes the likelihood of the patient developing a ...